Filing Details

Accession Number:
0001209191-10-054120
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-11-10 11:17:16
Reporting Period:
2010-11-08
Filing Date:
2010-11-10
Accepted Time:
2010-11-10 11:17:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
890846 Uroplasty Inc UPI Surgical & Medical Instruments & Apparatus (3841) 411719250
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1374449 Jones A Lee 54 Locke Lake Rd
Fridley MN 55432
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-11-08 45,000 $1.82 55,725 No 4 M Direct
Common Stock Disposition 2010-11-08 25,765 $5.60 29,960 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock non-qualified stock options Disposition 2010-11-08 45,000 $1.82 45,000 $1.82
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2006-08-28 2011-08-27 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock non-qualified stock options $0.77 2009-09-15 2014-09-14 15,000 15,000 Direct
Common Stock non-qualified stock options $4.16 2011-09-14 2017-09-13 6,175 6,175 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2014-09-14 15,000 15,000 Direct
2017-09-13 6,175 6,175 Direct
Footnotes
  1. Includes 3,625 shares of restricted stock subject to risk of forfeiture that lapses six months from the grant date (September 14, 2010).
  2. Fully vested.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions pursuant to a 10b5-1 plan adopted by Ms. Jones in September 2010 at prices ranging from $5.50 to $5.72 per share, inclusive. The reporting person undertakes to provide to Uroplasty, Inc., any security holder of Uroplasty, Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) .